Prostate Cancer - Results from #80

Systematic versus Targeted MRI/Ultrasound Fusion Prostate Biopsy Among Men with MRI-Visible Lesions. August 26, 2021

Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. August 26, 2021

First Patient Treated in Clarity's Cu-64/Cu-67 SAR-bisPSMA Theranostic Prostate Cancer Trial August 25, 2021

Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers. August 25, 2021

Radium-223 plus Enzalutamide versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. August 25, 2021

Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk. August 25, 2021

Use of docetaxel in low- and high-burden metastatic hormone-sensitive prostate cancer: A systematic review and assessment of subgroup analyses. August 25, 2021

Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital. August 24, 2021

Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer. August 24, 2021

Factors Associated With Discontinuation of Active Surveillance among Men With Low-Risk Prostate Cancer: A Population-Based Study. August 24, 2021

Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275). August 24, 2021

Telix and Lightpoint Medical to Collaborate on Radioguided Surgery August 23, 2021

Novel Automated 3D Surgical Planning Tool and MRI/Ultrasound Fusion Technology to Perform Nanoparticle Ablation and Cryoablation of the Prostate for Focal Therapy. August 23, 2021

Effects of Exercise on Cardiorespiratory Fitness and Biochemical Progression in Men With Localized Prostate Cancer Under Active Surveillance: The ERASE Randomized Clinical Trial. August 23, 2021

Circulating and intra-tumoral adrenal androgens correlate with response to abiraterone in men with castration resistant prostate cancer. August 23, 2021

The role of chromodomain helicase DNA binding protein 1 (CHD1) in promoting an invasive prostate cancer phenotype. August 23, 2021

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. August 23, 2021

Prostate cancer active surveillance outcomes in a cohort composed primarily of African American and Hispanic American Men. August 20, 2021

Reduced Acquisition Time Per Bed Position for PET/MRI Using 68Ga-RM2 or 68Ga-PSMA11 in Patients With Prostate Cancer: A Retrospective Analysis. August 20, 2021

Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT. August 20, 2021

Page 5 of 1173